Regulatory Work to Secure Licence Variation for anastrozole
A Tender Notice
by NHS ENGLAND
- Source
- Contracts Finder
- Type
- Contract (Services)
- Duration
- 1 year
- Value
- £0-£1
- Sector
- HEALTH
- Published
- 23 Dec 2021
- Delivery
- 01 Apr 2022 to 31 Mar 2023
- Deadline
- 31 Jan 2022 13:00
Concepts
Location
Geochart for 1 buyers and 0 suppliers
1 buyer
- NHS England Runcorn
Description
This Tender is solely for the work involved to apply for and implement a major (type II) MHRA Marketing Authorisation variation to add a new clinical indication for anastrozole. The successful Bidder will be responsible for ensuring that all relevant MHRA conditions and documentation for the Marketing Authorisation variation are met and submitted within the time limits agreed with the Authority. In return the Authority will fund actual and reasonably incurred costs associated with obtaining this licence variation only. Full details can be found on the Atamis portal: https://health-family.force.com/s/Welcome Closing date for submissions is 31st January 2022 at 13:00
CPV Codes
- 33600000 - Pharmaceutical products
Reference
- CF-0547300D0O000000rwimUAA1
- CF f39f6b29-1516-4aa5-b06d-6446dbc7e777